News Releases Year: All News2020201920182017201620152014201320122011 Items per page All News2550 December 1, 2020 Summary ToggleAllena Pharmaceuticals Announces Appointment of David J. Clark, M.D., M.R.C.P. as Chief Medical Officer Read more November 30, 2020 Summary ToggleAllena Pharmaceuticals Announces Initial Data from Phase 1 Trial of ALLN-346 Read more November 24, 2020 Summary ToggleAllena Pharmaceuticals to Present Virtually at Evercore ISI 3rd Annual HealthCONx Conference Read more November 9, 2020 Summary ToggleAllena Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update Read more November 3, 2020 Summary ToggleAllena Pharmaceuticals to Participate Virtually in Upcoming Investor Conferences in November Read more October 5, 2020 Summary ToggleAllena Pharmaceuticals Appoints Ann Miller, M.D. to its Board of Directors Read more September 30, 2020 Summary ToggleAllena Pharmaceuticals Announces $25 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures Read more September 8, 2020 Summary ToggleAllena Pharmaceuticals Doses First Subject in Phase 1 Clinical Trial of ALLN-346, in Development for the Treatment of Hyperuricemia in Patients with Gout and Advanced Chronic Kidney Disease Read more September 3, 2020 Summary ToggleAllena Pharmaceuticals to Present Virtually at Upcoming Investor Conferences in September Read more August 5, 2020 Summary ToggleAllena Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update Read more Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
